The gut microbiome is believed to play an important role in human health in areas as diverse as brain function and the immune system. Exploring host-microbiome interactions will provide a mechanistic understanding and enable new insights in human diseases (i.e., their diagnosis, prognosis and treatment) and new perceptions of xenobiotic efficacy and/or toxicity. This workshop will review the science and initiate discussions on multiple topics, including a) identification of biomarkers of toxicity for alterations in gut microbial function, b) if changes in the microbiome can affect efficacy of medicines and c) if exposure to xenobiotics can eventually result in a disease state through changes in the microbiome. Conclusions from his workshop will help determine where the data gaps are so that researchers can start answering these questions.
To identify data gaps that can be addressed to help determine if alterations in the gut microbiome have an effect on human health.
1. To discuss and review the current science on the gut microbiome and identify areas of interest regarding its role in human health
2. To discuss our understanding on how xenobiotic toxicity affects the microbiome
3. To understand if there are biomarkers of disease or organ damage due to:
• alterations of microbiome structure and function
• endogenous microbial metabolites
REGISTRATION FOR WORKSHOP WILL OPEN EARLY 2018.
Thank you for your interest in the HESI Microbiome Workshop. To receive an alert when registration is open please provide your contact information below:
Drugging Gut Microbial Enzymes for the Treatment of Cardiometabolic Disease
Mark Brown, Cleveland Clinic
Overview of Biotransformation of Xenobiotics by Microbiota
Julia Cui, University of Washington [Download Presentation]
Gut Microbial Transformation – Endogenous and Exogenous Metabolites & Effect of Xenobiotics on Microbial Composition and Endogenous Functions
Gary Perdew, Penn State University
Modification of Chemical Effects by Microbiome?
Andrew Patterson, Penn State University
What is an Adverse Effect?
Rodney Dietert, Cornell University [Download Presentation]
Where to Look for Biomarkers?
Carrie Brodmerkel, Janssen [Download Presentation]
Challenges in Determining Sensitive Biomarkers of Dysbiosis When Assessing the Impact of Antimicrobial Drug Residues in Food on the Human Intestinal Microbiome
Carl Cerniglia, US FDA-NCTR [Download Presentation]
What are the Tools and Technologies Needed?
Joseph Petrosino, Baylor College of Medicine [Download Presentation]
Toxicity and Environmental Pollutants
Kun Lu, University of North Carolina Chapel Hill
Identification of Microbiome-based Biomarkers and Challenges Associated with their Application: Case Studies from Obesity, IBD, and Cancer
Emily Hollister, Diversigen [Download Presentation]
The Microbiome and Hypertension
Elaine Richards Sumners, University of Florida [Download Presentation]
Health Insights from Microbiomes in the Context of Personal, Dense, Dynamic, Data Clouds
Nathan Price, Institute for Systems Biology
Age – Early & Late Life
Eugene Chang, University of Chicago [Download Presentation]
Gender and the Gut Microbiome
Marijke Faas, University of Groningen
Overview of Key Factors Known to Affect Composition of Laboratory Rodent Gut Microbiome
Aaron Ericsson, University of Missouri [Download Presentation]
Natural World Versus Laboratory World: Natural Gut Microbiota from Wild Mice Improve Host Fitness in Viral Infection and Carcinogenesis Models
Barbara Rehermann, NIH/NIDDK [Download Presentation]
Investigating Interactions Between Chemicals and Microbiota in Zebrafish
Tamara Tal, US EPA